Macrophage membrane-decorated MnO2 nanozyme catalyzed the scavenging of estradiol for endometriosis treatment

Colloids Surf B Biointerfaces. 2024 Jan:233:113633. doi: 10.1016/j.colsurfb.2023.113633. Epub 2023 Nov 7.

Abstract

Endometriosis (EMs) is an inflammatory, estrogen-dependent disease characterized by the growth of endometrial-like tissue outside the uterus. Despite many efforts to develop effective treatment regimens, the overall response to halting EMs progression so far remains unsatisfactory. Herein, we explored and synthesized a biomimic macrophage membrane-decorated MnO2 nanosheet (MM-NS) as a nanozyme capable of scavenging estrogen for EMs treatment. This nanosystem exhibited good solubility and potent estradiol scavenging activities. As expected, MM-NS effectively inhibited cell proliferation and inflammation in an estradiol scavenging-dependent way. In vivo MM-NS targeted to ectopic lesions and effectively suppressed lesion growth in endometriosis mice model, which could be attributed to the inhibition of tissue proliferation and the lower levels of inflammatory factors in peritoneal fluid. Taken together, this study not only revealed a new application scenario for nanozyme but also developed a novel endometriosis treatment strategy by catalyzing the scavenging of estrogen.

Keywords: Endometriosis; Estrogen scavenging; Macrophage membrane-decorated nanocarriers; Nanozyme.

MeSH terms

  • Animals
  • Catalysis
  • Endometriosis* / drug therapy
  • Estradiol* / pharmacology
  • Estrogens
  • Female
  • Humans
  • Macrophages
  • Manganese Compounds / pharmacology
  • Mice
  • Oxides / pharmacology

Substances

  • Estradiol
  • Manganese Compounds
  • Oxides
  • Estrogens